Kazia Therapeutics Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Kazia Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $28.82. The average 1-year stock price forecast is 301.39% higher than the current stock price, while the lowest is $17.26 (+140.39%) and the highest is $39.19 (+445.82%).

Price Target: $28.82 (+301.39%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$17.26	$28.82	$29.53	$39.19
Change	+140.39%	+301.39%	+311.28%	+445.82%

Analyst Ratings

The average analyst rating for Kazia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	1	2	3	4	4	6
Buy	2	2	2	2	2	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	5	6	6	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $29	Buy	Maintains	$29	+303.90%	Nov 3, 2026
Unknown Analyst Needham No rating	Needham	Buy Initiates $27	Buy	Initiates	$27	+276.04%	Oct 30, 2026
Kambiz Yazdi BTIG	BTIG	Buy Maintains $40	Buy	Maintains	$40	+457.10%	Oct 22, 2026
Paul Jeng Guggenheim	Guggenheim	Buy Initiates $35	Buy	Initiates	$35	+387.47%	Oct 21, 2026
Andrew Berens Leerink Partners	Leerink Partners	Buy Initiates $30	Buy	Initiates	$30	+317.83%	Oct 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

848.12K

from 1.83M

-53.63%

from 1.83M

Revenue Next Year

809.25K

from 848.12K

-4.58%

from 848.12K

EPS This Year

-0.05

EPS Next Year

n/a

from -0.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	15.18M	10.00K	1.00K	2.48M	1.83M	848.12K
Revenue Growth	1,436.54%	-99.93%	-90.00%	248,000.00%	-26.28%	-53.63%
Operating Income	-6.38M	-25.38M	-24.15M	-28.46M	-14.22M	-25.51M
Net Income	-8.42M	-25.01M	-20.47M	-26.78M	-20.70M	-25.69M
EPS	-	-	-	-	-	-0.05
Free Cash Flow	-	-	-	-	-	-24.90M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	2.8M
Avg	848,120
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	53.1%
Avg	-53.6%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.05
Avg	-0.05
Low	-0.05

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-